Warning: The NCBI web site requires JavaScript to function. more...
World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility.
Bacon DJ, Jambou R, Fandeur T, Le Bras J, Wongsrichanalai C, Fukuda MM, Ringwald P, Sibley CH, Kyle DE.
Malar J. 2007 Sep 6;6:120.
Related citations
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
Price RN, Dorsey G, Ashley EA, Barnes KI, Baird JK, d'Alessandro U, Guerin PJ, Laufer MK, Naidoo I, Nosten F, Olliaro P, Plowe CV, Ringwald P, Sibley CH, Stepniewska K, White NJ.
Malar J. 2007 Sep 6;6:119.
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.
Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ.
Malar J. 2007 Sep 6;6:121.
World Antimalarial Resistance Network (WARN) IV: clinical pharmacology.
Barnes KI, Lindegardh N, Ogundahunsi O, Olliaro P, Plowe CV, Randrianarivelojosia M, Gbotosho GO, Watkins WM, Sibley CH, White NJ.
Malar J. 2007 Sep 6;6:122.
The rationale and plan for creating a World Antimalarial Resistance Network (WARN).
Sibley CH, Barnes KI, Plowe CV.
Malar J. 2007 Sep 6;6:118.
[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M.
Sante. 2008 Jan-Mar;18(1):43-7. French.
A network to monitor antimalarial drug resistance: a plan for moving forward.
Sibley CH, Barnes KI, Watkins WM, Plowe CV.
Trends Parasitol. 2008 Jan;24(1):43-8. Epub 2007 Nov 26. Review.
[Drug-resistant malaria: problems with its definition and technical approaches].
Basco L, Ringwald P.
Sante. 2000 Jan-Feb;10(1):47-50. French.
Sentinel network for monitoring in vitro susceptibility of Plasmodium falciparum to antimalarial drugs in Colombia: a proof of concept.
Aponte SL, Díaz G, Pava Z, Echeverry DF, Ibarguen D, Rios M, Murcia LM, Quelal C, Murillo C, Gil P, Björkman A, Osorio L.
Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1:123-9.
Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
Bacon DJ, Latour C, Lucas C, Colina O, Ringwald P, Picot S.
Antimicrob Agents Chemother. 2007 Apr;51(4):1172-8. Epub 2007 Jan 12.
In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.
Legrand E, Volney B, Meynard JB, Mercereau-Puijalon O, Esterre P.
Antimicrob Agents Chemother. 2008 Jan;52(1):288-98. Epub 2007 Oct 22.
Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.
Suwandittakul N, Chaijaroenkul W, Harnyuttanakorn P, Mungthin M, Na Bangchang K.
Korean J Parasitol. 2009 Jun;47(2):139-44. Epub 2009 May 27.
Drug resistance in malaria.
Parija SC, Praharaj I.
Indian J Med Microbiol. 2011 Jul-Sep;29(3):243-8. Review.
Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
Na-Bangchang K, Karbwang J.
Fundam Clin Pharmacol. 2009 Aug;23(4):387-409. Review.
Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN).
Lourens C, Watkins WM, Barnes KI, Sibley CH, Guerin PJ, White NJ, Lindegardh N.
Malar J. 2010 Dec 25;9:375.
The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen.
Al-Shamahy H, Al-Harazy AH, Harmal NS, Al-Kabsi AM.
Ann Saudi Med. 2007 Nov-Dec;27(6):432-6.
Monitoring antimalarial resistance: launching a cooperative effort.
Sibley CH, Guerin PJ, Ringwald P.
Trends Parasitol. 2010 May;26(5):221-4. Epub 2010 Mar 20.
Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations.
Travassos MA, Laufer MK.
Pediatr Res. 2009 May;65(5 Pt 2):64R-70R. Review.
Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali.
Kaddouri H, Djimdé A, Dama S, Kodio A, Tekete M, Hubert V, Koné A, Maiga H, Yattara O, Fofana B, Sidibe B, Sangaré CP, Doumbo O, Le Bras J.
Int J Parasitol. 2008 Jun;38(7):791-8. Epub 2008 Jan 3.
Novel molecular targets for antimalarial chemotherapy.
Jana S, Paliwal J.
Int J Antimicrob Agents. 2007 Jul;30(1):4-10. Epub 2007 Mar 6. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on